Form 4 for SLS SELLAS Life Sciences Group, Inc.
Accepted 2023-12-08 00:00:00 ET · period of report 2023-12-06 · accession 0001104659-23-124688 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-12-08 | 2023-12-06 | SLS | Stergiou Angelos M. | Pres, CEO, Dir | J - Other | $1.08 | -12.3K | 217.4K | -5% | -$13.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-12-06 | J | D | 12,268 | $1.08 | 217,421 | D | — | — | (F2) Represents the number shares of common stock withheld by the Issuer to cover tax withholding obligations of the Reporting Person in connection with the vesting of RSUs. |